Last updated February 21, 2019 at 4:38 pm
While cancer might be devastating Tasmanian devils, a new study has found the contagious tumours are unlikely to cause their extinction.
A provocative study of Tasmanian devils has revealed that a transmissible cancer that has devastated devil populations in recent years is unlikely to cause extinction of the iconic species.
New research led by Dr Konstans Wells from Swansea University has revealed that it is more likely that the disease will fade out or that the devils will coexist with Tasmanian Devil Facial Tumour Disease (DFTD) in future.
DFTD typically kills the majority of devils it infects and has wiped out about ~80% of wild devils, with continuous decline of existing populations since the disease was first identified.
An international team of scientists from the UK, Australia and the USA matched field epidemiological evidence from wild populations collected over a 10-year period in north-west Tasmania with simulation studies, which revealed that DFTD is unlikely to continue causing ongoing population declines of Tasmanian devils in future.
They say the findings of their study, published in Ecology, offers much-needed hope that the species, which is the world’s largest remaining marsupial carnivore, will not necessarily become extinct from DFTD.
Tasmanian Devil Facial Tumour Disease
First discovered in north-eastern Tasmania in 1996, DFTD causes tumours to form on the face and neck of the animal. The cancer spreads when the devils bite each other’s faces during fighting, and kills the animals within six to nine months.
Dr Konstans Wells, lead author of the study, said: “Our findings suggest that immediate management interventions are unlikely to be necessary to ensure the survival of Tasmanian devil populations. This is because strong population declines of devils after disease emergence do not necessarily translate into long-term population declines.”
To explore the long-term outcomes of DFTD and devil populations, the researchers conducted a large number of simulations of possible disease spread in devils. Based on evidence such as current infection rates in the wild, the most likely simulations scenarios were selected to explore how DFTD will affect devil populations over the next 100 years . Among the most likely scenarios were those in which DFTD faded out (57% of likely scenarios) or coexisted with devils (22% of likely scenarios).
“With growing evidence that devils are showing signs of adaptation to DFTD and that so far the disease has not caused local extinctions, management actions targeted at understanding the devil’s adaptive strategies to cope with DFTD should be considered,” co-author Dr Rodrigo Hamede from the University of Tasmania said.
Eradication not feasible
“Complete eradication of DFTD is not feasible, therefore studying the long-term interactions between devils and tumours will provide a realistic prognosis for the species and at the same time will help us to understand important evolutionary processes. This is particularly relevant given the recent outbreak of a new transmissible cancer (devil facial tumour 2) affecting devil populations in south-eastern Tasmania.
“Devils seem to be prone to transmissible cancers, so studying epidemic dynamics and evolutionary responses to these type of diseases should be a priority,” Dr Hamede said.
The research suggests that management efforts to maintain devil populations should be guided by the changing understanding of the long-term outcome of the disease impact on devils.
“Management efforts in wild populations that solely aim to combat the impact of DFTD can be counterproductive if they disrupt long-term forces at work that may eventually lead to stable devil populations that are well able to persist with the cancer,” Dr Wells explained.
“Wildlife diseases such as DFTD should not disguise the fact that sufficiently large and undisturbed natural environments are a vital prerequisite for wildlife to persist and eventually cope with obstructions such as infectious diseases without human intervention.”